Nuno M. Neves & Rui L. Reis 
Biomaterials from Nature for Advanced Devices and Therapies [EPUB ebook] 

In-depth information on natural biomaterials and their applications for translational medicine!

* Undiluted expertise: edited by world-leading experts with contributions from top-notch international scientists, collating experience and cutting-edge knowledge on natural biomaterials from all over the world

* A must-have on the shelf in every biomaterials lab: graduate and Ph D students beginning their career in biomaterials science and experienced researchers and practitioners alike will turn to this comprehensive reference in their daily work

* Link to clinical practice: chapters on translational research make readers aware of what needs to be considered when a biomaterial leaves the lab to be routinely used

关于作者

Nuno M. Neves is Professor at the Department of Polymer Engineering of the University of Minho, Portugal, where he is Vice-Director of the 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics. Nuno M. Neves received his Ph D degree in Polymer Science and Engineering from the University of Minho in collaboration with the University of Twente, The Netherlands. His main area of research is the development of biomaterials from natural origin polymers. His research group focuses mainly on tissue engineering and regenerative medicine strategies using stem cells and advanced drug delivery scaffolds and medical devices.

Rui L. Reis is Professor of Tissue Engineering, Regenerative Medicine, Biomaterials and Stem Cells at the Department of Polymer Engineering of the University of Minho, Portugal. He is the Vice-Rector for Research of the University of Minho, Director of the 3B’s Research Group and the Director of the Portuguese Government Associate Laboratory ICVS/3B’s. Rui L. Reis received his Ph D degree in Polymer Engineering from the University of Minho in collaboration with Brunel University in London, UK. His main area of research is the development of biomaterials from natural origin polymers that his group proposes for a range of biomedical applications.